IP Library Granted Patent US 8,372,598
Granted Patent B2
US 8,372,598 · App. 13/159,293 · Granted Feb 12, 2013

Salt selection of microbial mutants to increase bioproduct tolerance, titer, or osmotic shock tolerance

Inventor: Jeanette M. Mucha (San Carlos, CA)
Assignee: Cobalt Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,372,598
App. No.
13/159,293
Granted
Feb 12, 2013
Kind
B2
Abstract

Methods are provided for selecting microbial strains with improved properties for fermentation and/or bioproduct production. A salt selection is employed to identify mutants with improved bioproduct tolerance, titer, or osmotic tolerance relative to a microbial strain from which they were derived.

Claims (12)

1. A method for selecting a microbial strain with increased tolerance to a bioproduct that is produced by and is toxic to said microbial strain, comprising culturing mutants of a bioproduct-producing microbial strain on solid growth medium or in liquid growth medium that comprises salt at a concentration sufficient to inhibit growth of the bioproduct-producing microbial strain by at least about 99%, selecting microbial colonies that grow in the presence of said salt, and identifying a bioproduct tolerant microbial strain by assessing the bioproduct tolerance of said colonies.

2. A method according to claim 1 , wherein bioproduct tolerance is at least about 5% higher in the bioproduct tolerant microbial strain relative to the bioproduct-producing microbial strain from which it was derived.

3. A method according to claim 1 , wherein the bioproduct is a solvent.

4. A method according to claim 3 , wherein the solvent comprises butanol.

5. A method according to claim 1 , wherein the growth medium comprises at least about 50 mM salt.

6. A method according to claim 1 , wherein the microbial strain is bacterial or fungal.

7. A method according to claim 6 , wherein the microbial strain is a bacterial species of Clostridium, Lactobacillus, Enterococcus, Escherichia, Bacillus, Pichia, Pseudomonas, Synechocystis , or Saccharomyces.

8. A method according to claim 7 , wherein the bacterial strain is a Clostridium species.

9. A method according to claim 8 , wherein the Clostridium species is Clostridium acetobutylicum, Clostridium beijerinckii, Clostridium saccharobutylicum, Clostridium puniceum, Clostridium saccharoperbutylacetonicum, Clostridium pasteuranium, Clostridium butylicum, Clostridium aurantibutyricum, Clostridium tetanomorphum, Clostridium thermocellum , or Clostridium thermosaccharolyticum.

10. A method according to claim 1 , wherein the salt is an inorganic salt.

11. A method according to claim 10 , wherein the salt is selected from sodium chloride, potassium chloride, potassium phosphate, ammonium sulfate, calcium chloride, and calcium phosphate, or a mixture thereof.

12. A method for selecting a microbial strain that produces a bioproduct at an increased titer in comparison with a bioproduct producing parent strain, comprising culturing mutants of a bioproduct-producing microbial strain on solid growth medium or in liquid growth medium that comprises salt in an amount sufficient to inhibit growth of the bioproduct producing parent strain by at least about 99%, selecting microbial colonies that grow in the presence of said salt, and identifying said microbial strain that produces bioproduct at an increased titer by assessing the bioproduct titer of said colonies when grown in fermentation medium under conditions suitable for bioproduct production.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2015
From: THE WHITTEMORE COLLECTION, LTD; PINNACLE VENTURES EQUITY FUND I, L.P.; PINNACLE VENTURES EQUITY FUND I AFFILIATES, L.P.; PINNACLE VENTURES EQUITY FUND I-O, L.P.; PINNACLE VENTURES II-A, L.P.; PINNACLE VENTURES II-B, L.P.; PINNACLE VENTURES II-C, L.P.; PINNACLE VENTURES II-R, L.P.; MALAYSIAN LIFE SCIENCES CAPITAL FUND, LTD; VANTAGEPOINT VENTURE PARTNERS 2006 (Q), L.P.; VANTAGEPOINT CLEANTECH PARTNERS, L.P.; LSP BIOVENTURES C.V.; @VENTURES V, LLC; HARRIS & HARRIS GROUP, INC.
To: COBALT TECHNOLOGIES, INC.
Reel/Frame 036872/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2015
From: COBALT (ASSIGNMENT FOR THE BENEFIT OF CREDITORS) LLC
To: TALFRYN SA
Reel/Frame 036804/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2015
From: COBALT TECHNOLOGIES, INC.
To: COBALT (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 036250/0743 →
SECURITY AGREEMENT Recorded May 31, 2012
From: COBALT TECHNOLOGIES, INC.
To: THE WHITTEMORE COLLECTION, LTD.; PINNACLE VENTURES EQUITY FUND I, L.P.; PINNACLE VENTURES EQUITY FUND I AFFILIATES, L.P.; PINNACLE VENTURES EQUITY FUND I-O, L.P.; PINNACLE VENTURES II-A, L.P.; PINNACLE VENTURES II-B, L.P.; PINNACLE VENTURES II-C, L.P.; PINNACLE VENTURES II-R, L.P.; LSP BIOVENTURES C.V.; @VENTURES V, LLC; VANTAGEPOINT VENTURE PARTNERS 2006 (Q), L.P.; VANTAGEPOINT CLEANTECH PARTNERS, L.P.; HARRIS & HARRIS GROUP, INC.; MALAYSIAN LIFE SCIENCES CAPITAL FUND, LTD
Reel/Frame 028307/0364 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2011
From: MUCHA, JEANETTE M.
To: COBALT TECHNOLOGIES, INC.
Reel/Frame 026786/0732 →
Continuity (2)
Provisional Application 61354567 · Jun 14, 2010
Related Publication 20110306083A1 · Dec 15, 2011